Diagast Overview

  • Year Founded
  • 1968

Year Founded

  • Status
  • Private

  • Employees
  • 226

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

  • Investments
  • 1

Diagast General Information

Description

Manufacturer of medical systems intended for the determination of blood groups. The company engages in the development, production, and marketing of reagents and automated systems intended for making safer computer-aided decisions, enabling laboratories, hospitals, and blood banks to receive practical, accurate, and easy-to-use equipment.

Contact Information

Website
www.diagast.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Parc Eurasanté
  • 251, Avenue Eugène Avinée
  • 59120 Loos
  • France
+33 03
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Vertical(s)
Manufacturing
Corporate Office
  • Parc Eurasanté
  • 251, Avenue Eugène Avinée
  • 59120 Loos
  • France
+33 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diagast Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Diagast‘s full profile, request access.

Request a free trial

Diagast Patents

  • 79

    Total Documents Applications and Grants

  • Total Patents Families

  • 37

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Diagast Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019221625-A1 In vitro diagnosis device comprising beads and uses thereof Inactive 16-Feb-2018
EP-3752835-A1 In vitro diagnosis device comprising beads and uses thereof Pending 16-Feb-2018
US-12241894-B2 In vitro diagnosis device comprising beads and uses thereof Active 16-Feb-2018
US-20200408749-A1 In vitro diagnosis device comprising beads and uses thereof Active 16-Feb-2018
WO-2019158726-A1 In vitro diagnosis device comprising beads and uses thereof Inactive 16-Feb-2018 G01N33/5436
To view Diagast’s complete patent history, request access »

Diagast Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diagast Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Diagast‘s full profile, request access.

Request a free trial

Diagast Acquisitions (1)

Diagast’s most recent deal was a Merger/Acquisition with ABO Diag. The deal was made on 20-Mar-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ABO Diag 20-Mar-2014 Merger/Acquisition Diagnostic Equipment
To view Diagast’s complete acquisitions history, request access »

Diagast FAQs

  • When was Diagast founded?

    Diagast was founded in 1968.

  • Where is Diagast headquartered?

    Diagast is headquartered in Loos, France.

  • What is the size of Diagast?

    Diagast has 226 total employees.

  • What industry is Diagast in?

    Diagast’s primary industry is Monitoring Equipment.

  • Is Diagast a private or public company?

    Diagast is a Private company.

  • What is Diagast’s current revenue?

    The current revenue for Diagast is .

  • How much funding has Diagast raised over time?

    Diagast has raised $6.44M.

  • Who are Diagast’s investors?

    Generation Entrepreneurs Investisseurs has invested in Diagast.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process